Sleep Apnea: On Zepbound, Testosterone and GH Labels
[Glossary · How doses act in the body]

Sleep apnea

Also called obstructive sleep apnea, OSA · Reviewed

Definition: Sleep apnea is a common condition in which breathing stops and restarts many times during sleep, NHLBI says. In obstructive sleep apnea (OSA), the most common type, the upper airway becomes blocked again and again. The NCI dictionary describes pauses of 10 seconds or more, with loud snoring and daytime sleepiness as symptoms.

Three ways it shows up on labels

  • As a use: Zepbound is approved to treat moderate to severe obstructive sleep apnea in adults with obesity.
  • As a warning: the AndroGel label says testosterone may worsen sleep apnea, especially with obesity or chronic lung disease. The other testosterone labels on this site carry the same warning.
  • As a reason to pause: Genotropin reports deaths after starting growth hormone in children with Prader-Willi syndrome who had severe obesity, airway blockage or sleep apnea. They are checked for airway problems first, and treatment is paused if snoring starts or gets worse.

Signs people notice

NHLBI suggests asking a provider about sleep apnea if someone says you snore or gasp for air in your sleep, or if you have heavy daytime sleepiness. It is diagnosed with a sleep study.

Why it matters for your log

New or louder snoring after starting testosterone is the kind of change a partner notices before you do. A note with the date, next to dose changes, helps a prescriber decide whether a sleep study is worth doing.

Read more on Dose Track: Sleep apnea on TRT · Zepbound side effects · AndroGel side effects · Sleep

General education drawn from labels and published studies, not personal medical advice. Your prescriber, pharmacist and the label that came with your product are the final word.

Frequently asked questions

Can testosterone make sleep apnea worse?+
The AndroGel label says it may, especially in people with obesity or chronic lung disease.
Is any medicine approved for sleep apnea?+
Zepbound (tirzepatide) is approved to treat moderate to severe obstructive sleep apnea in adults with obesity, alongside diet and activity.